Senti Biosciences Holdings, Inc.
Public company- Headquarters
- SOUTH SAN FRANCISCO, California
- Industry
- Biotechnology
- Ticker
- SNTI
- CIK
- 0001854270
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| DirectorEdward Mathers | Oct 27, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Cardiff Oncology, Inc.
CMO appointed: Leila Alland
- Vaxart, Inc.
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
- Executive departure
Director departs: Edward Mathers
Edward Mathers, Director of Senti Biosciences Holdings, Inc., resigns the role, effective October 27, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 27, 2026Role: Director
- Executive departure
Director departs: Brenda Cooperstone, Ph.D.
Brenda Cooperstone, Ph.D., Director of Senti Biosciences Holdings, Inc., resigns the role, effective September 23, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 24, 2026Role: Director
Last verified Nov 8, 2026